Jack W. Singer

NorthShore University HealthSystem — United States

Medicine · Health Sciences

99h-index34.7kcitations603works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(225), Acute Myeloid Leukemia Research(80), Chronic Lymphocytic Leukemia Research(59), Chronic Myeloid Leukemia Treatments(56), Neutropenia and Cancer Infections(54)

Publications592 total

Septische Arthritis und bakterielle Osteomyelitis im Kindesalter – Trend der letzten 30 Jahre
Arthritis und Rheuma·2025
Loeys Dietz Syndrome and Epithelioid Hemangioendotheliomaloeys-dietz Syndrome and Epithelioid Hemangioendothelioma
American Journal of Respiratory and Critical Care Medicine·2025
Abnormal Lung Infections in an Immunocompetent Patient – Middle Lobe Syndrome
American Journal of Respiratory and Critical Care Medicine·2025
Carry-On Lungs: Use of Commercial Airline Flights as a Cost Saving Measure in Lung Transplantation
The Journal of Heart and Lung Transplantation·2025Open Access
The Lung Transplant Consortium (LTC) Promise Lung Study: Collecting Data to Guide Best Practices
The Journal of Heart and Lung Transplantation·2025· 1 citedOpen Access
Supplementary Figure 1 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 4 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Data from Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-β Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib
2023Open Access
Supplementary Figure 3 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 5 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Materials, Figures 1-4, Tables 1-2 from Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-β Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib
2023Open Access
Supplementary Figure 2 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Data from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Data from Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-β Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib
2023Open Access
Supplementary Figure 4 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 5 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Data from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 2 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 1 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Table 1 from Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
2023Open Access
page 1 of 30Next →

Frequent Co-authors

CD Buckner(23), Rainer Storb(16), FR Appelbaum(11), Claudio Anasetti(10), H. Joachim Deeg(9), K Doney(8), K Lilleby(7), C. Dean Buckner(7), Jean E. Sanders(7), Eileen Bryant(7), Thomas Ed(6), F R Appelbaum(6), John A. Hansen(6), Clift Ra(5), LD Fisher(5), P Beatty(5), FR Appelbaum(5), E. Donnall Thomas(4), John Nemunaitis(4), R. A. Clift(4)